From October 1, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 19,086,325 shares, representing 3.39% for CNY 184.47 million under the buyback announced on February 2, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.75 CNY | +2.14% | +5.11% | +56.34% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+56.34% | 2.09B | |
+43.96% | 6.34B | |
-15.56% | 4.51B | |
-6.52% | 3.29B | |
+5.47% | 3.2B | |
-0.76% | 2.59B | |
-4.11% | 1.76B | |
+2.93% | 1.7B | |
-8.02% | 1.62B | |
+49.62% | 1.55B |
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Tranche Update on Henan Lingrui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 2, 2021.